These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31506887)

  • 61. Platelet Inhibition, Endothelial Function, and Clinical Outcome in Patients Presenting With ST-Segment-Elevation Myocardial Infarction Randomized to Ticagrelor Versus Prasugrel Maintenance Therapy: Long-Term Follow-Up of the REDUCE-MVI Trial.
    van der Hoeven NW; Janssens GN; Everaars H; Nap A; Lemkes JS; de Waard GA; van de Ven PM; van Rossum AC; Escaned J; Mejia-Renteria H; Ten Cate TJF; Piek JJ; von Birgelen C; Valgimigli M; Diletti R; Riksen NP; Van Mieghem NM; Nijveldt R; van Leeuwen MAH; van Royen N
    J Am Heart Assoc; 2020 Mar; 9(5):e014411. PubMed ID: 32122216
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Angiographic outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes).
    Kunadian V; James SK; Wojdyla DM; Zorkun C; Wu J; Storey RF; Steg PG; Katus H; Emanuelsson H; Horrow J; Maya J; Wallentin L; Harrington RA; Gibson CM
    JACC Cardiovasc Interv; 2013 Jul; 6(7):671-83. PubMed ID: 23866179
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of Chewing vs Swallowing Ticagrelor on Platelet Inhibition in Patients With ST-Segment Elevation Myocardial Infarction: A Randomized Clinical Trial.
    Asher E; Tal S; Mazin I; Abu-Much A; Sabbag A; Katz M; Regev E; Chernomordik F; Guetta V; Segev A; Elian D; Barbash I; Fefer P; Narodistky M; Beigel R; Matetzky S
    JAMA Cardiol; 2017 Dec; 2(12):1380-1384. PubMed ID: 29071332
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Coronary Heart Disease (CHD) in Elderly Patients: Which Drug to Choose, Ticagrelor and Clopidogrel? A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Akkaif MA; Sha'aban A; Daud NAA; Yunusa I; Ng ML; Sk Abdul Kader MA; Noor DAM; Ibrahim B
    J Cardiovasc Dev Dis; 2021 Sep; 8(10):. PubMed ID: 34677192
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Influence of intravenous fentanyl compared with morphine on ticagrelor absorption and platelet inhibition in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the PERSEUS randomized trial.
    Degrauwe S; Roffi M; Lauriers N; Muller O; Masci PG; Valgimigli M; Iglesias JF
    Eur Heart J Cardiovasc Pharmacother; 2019 Jul; 5(3):158-163. PubMed ID: 30101278
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clopidogrel, prasugrel or ticagrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention.
    Yudi MB; Clark DJ; Farouque O; Eccleston D; Andrianopoulos N; Duffy SJ; Brennan A; Lefkovits J; Ramchand J; Yip T; Oqueli E; Reid CM; Ajani AE;
    Intern Med J; 2016 May; 46(5):559-65. PubMed ID: 26909472
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Ticagrelor for patients with ST-segment elevation myocardial infarction after emergency percutaneous coronary intervention.
    Han L; Zhang JJ; Jing HF; Qin L
    J Biol Regul Homeost Agents; 2019 Mar-Apr,; 33(2):485-490. PubMed ID: 30892000
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of bioavailability and antiplatelet action of ticagrelor in patients with ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: A prospective, observational, single-centre study.
    Adamski P; Sikora J; Laskowska E; Buszko K; Ostrowska M; Umińska JM; Sikora A; Skibińska N; Sobczak P; Adamska U; Rość D; Kubica A; Paciorek P; Marszałł MP; Navarese EP; Gorog DA; Kubica J
    PLoS One; 2017; 12(10):e0186013. PubMed ID: 29023473
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy and safety analysis of new P2Y12 inhibitors versus clopidogrel in patients with percutaneous coronary intervention: a meta-analysis.
    Gan XD; Wei BZ; Fang D; Fang Q; Li KY; Ding SL; Peng S; Wan J
    Curr Med Res Opin; 2015 Dec; 31(12):2313-23. PubMed ID: 26402735
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Meta-Analysis of Potent P2Y12-ADP Receptor Antagonist Therapy Compared to Clopidogrel Therapy in Acute Coronary Syndrome Patients with Chronic Kidney Disease.
    Bonello L; Laine M; Lemesle G; Puymirat E; Dabry T; Thuny F; Paganelli F; Aradi D; Frere C; Burtey S; Sibbing D; Mancini J
    Thromb Haemost; 2018 Oct; 118(10):1839-1846. PubMed ID: 30235475
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Midterm follow-up outcomes of ticagrelor on acute ST segment elevation myocardial infarction undergoing emergency percutaneous coronary intervention].
    Xia JG; Qu Y; Hu SD; Xu J; Yin CL; Xu D
    Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Jun; 47(3):494-8. PubMed ID: 26080882
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Head-to-head comparison of prasugrel versus ticagrelor in patients undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials.
    Sakurai R; Burazor I; Bonneau HN; Kaneda H
    J Interv Cardiol; 2017 Oct; 30(5):457-464. PubMed ID: 28804959
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Meta-Analysis of Comparison of the Newer Oral P2Y12 Inhibitors (Prasugrel or Ticagrelor) to Clopidogrel in Patients With Non-ST-Elevation Acute Coronary Syndrome.
    Bavishi C; Panwar S; Messerli FH; Bangalore S
    Am J Cardiol; 2015 Sep; 116(5):809-17. PubMed ID: 26119655
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The MOVEMENT Trial.
    Holm M; Tornvall P; Henareh L; Jensen U; Golster N; Alström P; Santos-Pardo I; Witt N; Fedchenko N; Venetsanos D; Beck O; van der Linden J
    J Am Heart Assoc; 2019 Jan; 8(2):e010152. PubMed ID: 30636504
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [The Bleeding Safety of Ticagrelor in Patients With ST-Elevation Acute Coronary Syndrome Treated With Fibrinolytic Therapy].
    Bocharov AV; Sidorov DV
    Kardiologiia; 2020 Jul; 60(6):867. PubMed ID: 32720622
    [TBL] [Abstract][Full Text] [Related]  

  • 76. P2Y
    Guimarães LF; Généreux P; Silveira D; Pesaro AE; Falcão F; Barbosa BR; de Souza CF; Fonseca FA; Alves CM; Carvalho AC; Stone GW; Caixeta A
    Int J Cardiol; 2017 Mar; 230():204-208. PubMed ID: 28062136
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prasugrel versus clopidogrel in patients with ST-segment elevation myocardial infarction according to timing of percutaneous coronary intervention: a TRITON-TIMI 38 subgroup analysis (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis In Myocardial Infarction 38).
    Udell JA; Braunwald E; Antman EM; Murphy SA; Montalescot G; Wiviott SD
    JACC Cardiovasc Interv; 2014 Jun; 7(6):604-12. PubMed ID: 24947719
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Switching to Clopidogrel in Patients With Acute Coronary Syndrome Managed With Percutaneous Coronary Intervention Initially Treated With Prasugrel or Ticagrelor: Systematic Review and Meta-analysis.
    Hong J; Turgeon RD; Pearson GJ
    Ann Pharmacother; 2019 Oct; 53(10):997-1004. PubMed ID: 30999764
    [No Abstract]   [Full Text] [Related]  

  • 79. Effect of Clopidogrel vs Ticagrelor on Platelet Aggregation and Inflammation Markers After Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.
    Jiang Z; Zhang R; Sun M; Liu Q; Wang S; Wang W; Zhao Q; Zhang H; Wang Y; Hou J; Yu B
    Can J Cardiol; 2018 Dec; 34(12):1606-1612. PubMed ID: 30527148
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial.
    Shimada YJ; Bansilal S; Wiviott SD; Becker RC; Harrington RA; Himmelmann A; Neely B; Husted S; James SK; Katus HA; Lopes RD; Steg PG; Storey RF; Wallentin L; Cannon CP;
    Am Heart J; 2016 Jul; 177():1-8. PubMed ID: 27297843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.